Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C31H32N4O2.ClH |
| Molecular Weight | 529.072 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)CC2)C5=C1C=CC=C5
InChI
InChIKey=AJSZDJPJGGMSPW-UHFFFAOYSA-N
InChI=1S/C31H32N4O2.ClH/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25;/h3-16,26H,2,17-22H2,1H3;1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Bezitramide, an orally active analgesic. An investigation on pain following operations for lumbar disc protrusion (preliminary report). | 1970 Apr |
|
| Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. | 2003 Nov |
|
| The use of driving impairing medicines: a European survey. | 2009 Nov |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
145996662
Created by
admin on Sat Dec 16 11:32:41 GMT 2023 , Edited by admin on Sat Dec 16 11:32:41 GMT 2023
|
PRIMARY | |||
|
TAB8WY5HVX
Created by
admin on Sat Dec 16 11:32:41 GMT 2023 , Edited by admin on Sat Dec 16 11:32:41 GMT 2023
|
PRIMARY | |||
|
59708-44-0
Created by
admin on Sat Dec 16 11:32:41 GMT 2023 , Edited by admin on Sat Dec 16 11:32:41 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)
SUBSTANCE RECORD
